PacBio Announces Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Pacific Biosciences of California (PACB) PT Raised to $32 at Cowen
November 3, 2021 6:30 AM EDTCowen analyst Dan Brennan raised the price target on Pacific Biosciences of California (NASDAQ: PACB) to $32.00 (from $30.00) while maintaining a Market Perform rating.
The analyst commented, "PACB reported a good 3Q, with revenues +83% Y/Y, ~5% ahead of expectations, and service, consumables, & instrument revenues... More
